Ofloxacin

DNA topoisomerase II alpha ; Homo sapiens







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 26812543 RETRACTED: Ambient UV-B exposure reduces the binding of ofloxacin with bacterial DNA gyrase and induces DNA damage mediated apoptosis. 2016 Apr 1
2 23008691 Modified ionic liquid cold-induced aggregation dispersive liquid-liquid microextraction combined with spectrofluorimetry for trace determination of ofloxacin in pharmaceutical and biological samples. 2011 1
3 10887043 The impact of ofloxacin on rat testicular DNA: application of image analysis. 2000 Aug 1
4 10493278 Ofloxacin otic solution: a review of its use in the management of ear infections. 1999 Sep 1
5 10838268 A prospective, randomized, clinical study to compare the clinical safety, effectiveness, and cost of oral ofloxacin/clindamycin vs intravenous clindamycin/gentamicin for the treatment of postpartum endomyometritis. 1998 Jul 1 1
6 8013490 Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients. 1994 Feb 2
7 1723377 Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use. 1991 Nov 1
8 1850968 Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases. 1991 Feb 2
9 2842501 Synthesis and bacterial DNA gyrase inhibitory properties of a spirocyclopropylquinolone derivative. 1988 Sep 1
10 3028965 International experiences with ofloxacin, a new quinolone. 1986 1